Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Improved preparation method of II-type clopidogrel hydrogen sulfate crystal

A technology of clopidogrel hydrogen sulfate and clopidogrel free base, which is applied in directions such as organic chemistry, can solve problems such as low product yield, and achieve the effect of improving yield

Inactive Publication Date: 2014-01-22
吉林省博大伟业制药有限公司
View PDF5 Cites 15 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] The invention provides an improved method for preparing type II clopidogrel bisulfate crystals, which improves the existing preparation process, solves the problem of low product yield, and improves the appearance of the product

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Improved preparation method of II-type clopidogrel hydrogen sulfate crystal
  • Improved preparation method of II-type clopidogrel hydrogen sulfate crystal
  • Improved preparation method of II-type clopidogrel hydrogen sulfate crystal

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0049] Add 500ml of acetone to a 1000ml three-necked flask, heat to reflux, keep reflux for 10 minutes, stop heating, cool down to room temperature, and set aside.

[0050]At room temperature, 0.31mol of clopidogrel free base is used to prepare 300ml of acetone and stir to dissolve. Under the protection of nitrogen, add 31.0g (0.31mol) of concentrated sulfuric acid and 0.55g of II seed crystals. After white turbidity appears, continue stirring for 8 hours and filter , and dried under reduced pressure at 45°C for 16 hours to obtain 119.8 g of white crystals. Yield 92.0%; HPLC: normalized purity 99.994%, impurity A: 0.006%; melting point: 175.6°C; [α] D 25 +57.87 (C1.0, CH 3 OH); 1 HNMR (DMSO-d6, 600MH Z ), δ: 10.78 (br, 2H + ), δ: 7.73(d, 1H), δ: 7.67(d, 1H), δ: 7.58(t, 1H), δ: 54(t, 1H), δ: 7.44(d, 1H), δ: 6.90 (s, 1H), δ: 5.70 (s, 1H), δ: 4.27 (br, 2H), δ: 3.76 (s, 3H), δ: 3.52 (br, 2H), δ: 3.11 (s, 2H) . 13 CNMR (DMSO-d6, 600MH Z ), δ: 167.36, 134.40, 132.46, 131.70...

Embodiment 2

[0055] Add 500ml of acetone to a 1000ml three-necked flask, heat to reflux, keep reflux for 30 minutes, stop heating, cool down to room temperature, and set aside.

[0056] At room temperature, 0.31mol of clopidogrel free base is used to prepare 300ml of acetone and stir to dissolve. Under the protection of nitrogen, add 31.0g (0.31mol) of concentrated sulfuric acid and 0.55g of II seed crystals. After white turbidity appears, continue stirring for 8 hours and filter , dried under reduced pressure at 45°C for 16 hours to obtain 119.8g of white crystals, yield 92.7%, HPLC: normalized purity 99.993%, impurity A: 0.007%; melting point: 175.1°C; [α] D 25 +56.38 (C1.0, CH 3 OH), see attached Figure 9 .

Embodiment 3

[0058] Add 500ml of acetone to a 1000ml three-neck flask, heat to reflux, keep reflux for 40 minutes, stop heating, cool down to room temperature, and set aside.

[0059] At room temperature, 0.31mol of clopidogrel free base is used to prepare 300ml of acetone and stir to dissolve. Under the protection of nitrogen, add 31.0g (0.31mol) of concentrated sulfuric acid and 0.55g of II seed crystals. After white turbidity appears, continue stirring for 8 hours and filter , dried under reduced pressure at 45°C for 16 hours to obtain 121.4g of white crystals, yield 93.2%, HPLC: normalized purity 99.993%, impurity A: 0.007%; melting point: 174.8°C; [α] D 25 +56.55 (C1.0, CH 3 OH), see attached Figure 10 .

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an improved preparation method of a II-type clopidogrel hydrogen sulfate crystal, which is an improvement of the existing II-type clopidogrel hydrogen sulfate crystal form preparation technique. The method greatly enhances the yield on the premise of ensuring the product appearance (the average yield is up to 92%), and prepares the product with better appearance on the premise of obviously enhancing the product yield.

Description

[0001] technical field [0002] The invention discloses an improved preparation method of type II clopidogrel hydrogen sulfate crystal, which is an improvement on the existing preparation process of type II clopidogrel hydrogen sulfate crystal, and belongs to the technical field of chemical drug preparation. Background technique [0003] The present invention relates to clopidogrel hydrogensulfate (2s)-(2-chlorophenyl)[6.7-dihydrothiophene[3,2-c]pyridin-5(4H)-yl]acetate methyl ester hydrogensulfate, which The structure is as follows: [0004] [0005] Clopidogrel bisulfate is a new type of high-efficiency anti-platelet aggregation drug, which was first jointly developed by Japan's Daiichi Pharmaceutical and French Sanofi (Sanofi), and is clinically used in the treatment of atherosclerosis, acute coronary syndrome, prevention of In-stent restenosis and thrombotic complications after coronary stent implantation. Compared with other antiplatelet drugs, clopidogrel has the ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D495/04
CPCC07D495/04
Inventor 李晓东林杉黄晓光周凤秋
Owner 吉林省博大伟业制药有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com